IRIS Accounts Production v25.4.12.37 10585223 director 1.2.24 31.1.25 31.1.25 false true false false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 10585223 2024-01-31 10585223 2025-01-31 10585223 2024-02-01 2025-01-31 10585223 2023-01-31 10585223 2023-02-01 2024-01-31 10585223 2024-01-31 10585223 ns15:EnglandWales 2024-02-01 2025-01-31 10585223 ns14:PoundSterling 2024-02-01 2025-01-31 10585223 ns10:Director1 2024-02-01 2025-01-31 10585223 ns10:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 10585223 ns10:SmallEntities 2024-02-01 2025-01-31 10585223 ns10:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 10585223 ns10:SmallCompaniesRegimeForDirectorsReport 2024-02-01 2025-01-31 10585223 ns10:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 10585223 ns10:FullAccounts 2024-02-01 2025-01-31 10585223 1 2024-02-01 2025-01-31 10585223 ns10:RegisteredOffice 2024-02-01 2025-01-31 10585223 ns5:CurrentFinancialInstruments 2025-01-31 10585223 ns5:CurrentFinancialInstruments 2024-01-31 10585223 ns5:Non-currentFinancialInstruments 2025-01-31 10585223 ns5:Non-currentFinancialInstruments 2024-01-31 10585223 ns5:ShareCapital 2025-01-31 10585223 ns5:ShareCapital 2024-01-31 10585223 ns5:RetainedEarningsAccumulatedLosses 2025-01-31 10585223 ns5:RetainedEarningsAccumulatedLosses 2024-01-31 10585223 ns5:NetGoodwill 2024-02-01 2025-01-31 10585223 ns5:IntangibleAssetsOtherThanGoodwill 2024-02-01 2025-01-31 10585223 ns5:PlantMachinery 2024-02-01 2025-01-31 10585223 ns5:FurnitureFittings 2024-02-01 2025-01-31 10585223 ns5:NetGoodwill 2024-01-31 10585223 ns5:NetGoodwill 2025-01-31 10585223 ns5:NetGoodwill 2024-01-31 10585223 ns5:PlantMachinery 2024-01-31 10585223 ns5:FurnitureFittings 2024-01-31 10585223 ns5:PlantMachinery 2025-01-31 10585223 ns5:FurnitureFittings 2025-01-31 10585223 ns5:PlantMachinery 2024-01-31 10585223 ns5:FurnitureFittings 2024-01-31 10585223 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-01-31 10585223 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-01-31 10585223 ns5:MoreThanFiveYears ns5:Non-currentFinancialInstruments 2025-01-31 10585223 ns5:MoreThanFiveYears ns5:Non-currentFinancialInstruments 2024-01-31

REGISTERED NUMBER: 10585223 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 January 2025

for

Carbonlite Medical Technology Ltd

Carbonlite Medical Technology Ltd (Registered number: 10585223)

Contents of the Financial Statements

for the Year Ended 31 January 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 4 |

Carbonlite Medical Technology Ltd

Company Information

for the Year Ended 31 January 2025

| DIRECTOR: | S Khan

| REGISTERED OFFICE: | 20-22 Wenlock Road

| London

| N1 7GU

| REGISTERED NUMBER: | 10585223 (England and Wales)

Carbonlite Medical Technology Ltd (Registered number: 10585223)

Balance Sheet

31 January 2025

| 31.1.25 | 31.1.24 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Intangible assets | 4 | 68,000 |  | 76,500 |  |

Tangible assets | 5 | 12,627 |  | 16,694 |  |

80,627 |  | 93,194 |  |

CURRENT ASSETS

Stocks | 66,500 |  | 66,200 |  |

Debtors | 6 | 32,000 |  | 27,088 |  |

Cash at bank and in hand | 10 |  | 2,895 |  |

98,510 |  | 96,183 |  |

CREDITORS

Amounts falling due within one year | 7 | 18,756 |  | 28,417 |  |

NET CURRENT ASSETS | 79,754 |  | 67,766 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 160,381 |  | 160,960 |  |

CREDITORS

Amounts falling due after more than one year | 8 | 193,708 |  | 182,468 |  |

NET LIABILITIES | (33,327 | ) | (21,508 | ) |

CAPITAL AND RESERVES

Called up share capital | 1 |  | 1 |  |

Retained earnings | (33,328 | ) | (21,509 | ) |

SHAREHOLDERS' FUNDS | (33,327 | ) | (21,508 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Carbonlite Medical Technology Ltd (Registered number: 10585223)

Balance Sheet - continued

31 January 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 12 March 2026 and were signed by:

S Khan - Director

Carbonlite Medical Technology Ltd (Registered number: 10585223)

Notes to the Financial Statements

for the Year Ended 31 January 2025

1. | STATUTORY INFORMATION

| Carbonlite Medical Technology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Goodwill

| Goodwill, being the amount paid in connection with the acquisition of a business in 2017, is being amortised evenly over its estimated useful life of twenty years.

| Intangible assets

| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery | - | 10% on cost

| Fixtures and fittings | - | 10% on cost

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 1 (2024 - 1 ) .

4. | INTANGIBLE FIXED ASSETS

| Goodwill

£ |

| COST

| At 1 February 2024

| and 31 January 2025 | 170,000 |  |

| AMORTISATION

| At 1 February 2024 | 93,500 |  |

| Charge for year | 8,500 |  |

| At 31 January 2025 | 102,000 |  |

| NET BOOK VALUE

| At 31 January 2025 | 68,000 |  |

| At 31 January 2024 | 76,500 |  |

Carbonlite Medical Technology Ltd (Registered number: 10585223)

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

5. | TANGIBLE FIXED ASSETS

| Fixtures |

| Plant and |  | and |

| machinery |  | fittings |  | Totals

£ | £ | £ |

| COST

| At 1 February 2024

| and 31 January 2025 | 26,220 |  | 14,443 |  | 40,663 |  |

| DEPRECIATION

| At 1 February 2024 | 12,461 |  | 11,508 |  | 23,969 |  |

| Charge for year | 2,622 |  | 1,445 |  | 4,067 |  |

| At 31 January 2025 | 15,083 |  | 12,953 |  | 28,036 |  |

| NET BOOK VALUE

| At 31 January 2025 | 11,137 |  | 1,490 |  | 12,627 |  |

| At 31 January 2024 | 13,759 |  | 2,935 |  | 16,694 |  |

6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.1.25 |  | 31.1.24

£ | £ |

| Trade debtors | 32,000 |  | 25,725 |  |

| VAT | - |  | 1,363 |  |

32,000 |  | 27,088 |  |

7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.1.25 |  | 31.1.24

£ | £ |

| Bank loans and overdrafts | 13,485 |  | 20,147 |  |

| Tax | - |  | 4,770 |  |

| VAT | 21 |  | - |  |

| Accrued expenses | 5,250 |  | 3,500 |  |

18,756 |  | 28,417 |  |

8. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

| 31.1.25 |  | 31.1.24

£ | £ |

| Other loans - 2-5 years | 15,000 |  | 3,760 |  |

| Directors loan account | 178,708 |  | 178,708 |  |

193,708 |  | 182,468 |  |